Target intelligence / Profile preview

Bridging integrator 3 (BIN3)

Target
BIN3
Molecular classification
Other (BAR domain protein family), Adapter protein, Actin regulator
01

Overview

Bridging integrator 3 (BIN3) is a member of the BAR domain protein family, which bind to cell membranes, regulate actin dynamics, and contribute to processes such as cytokinesis and septation by helping localize F-actin. BIN3 contains a single BAR domain predicted to form coiled-coil structures allowing dimerization, interaction with small GTPases, and sensing or inducing membrane curvature[2][5]. The protein is implicated in endocytosis, membrane trafficking, and other forms of intracellular transport, and plays roles in the regulation of cell shape and division[2][5]. In cancer biology, lower expression of BIN3 correlates with poorer prognosis in several cancers, is associated with altered immune cell infiltration, and may function as a tumor suppressor, particularly in esophageal carcinoma[1]. Beyond oncology, genetic studies have implicated BIN3 in neurodevelopmental disorders, such as autism spectrum disorder[2]. There are currently no approved drugs or direct pharmacological modulators targeting BIN3.

Other names
BIN3Bridging integrator 3BAR domain-containing protein BIN3
02

Biological functions

CytokinesisSeptation (cell division)Actin cytoskeleton organizationMembrane curvature sensing and inductionIntracellular transportEndocytosisProtein localization
03

Disease associations

Cancer (tumor suppressor in several cancers, including esophagus carcinoma)Autism spectrum disorder (genetic association noted)Other (possible role in additional disorders due to general cell structure/function)
04

Biomarkers

BIN3 expression (as a prognostic biomarker for esophageal carcinoma[1])

Beyond the preview

Go deeper on Bridging integrator 3 (BIN3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bridging integrator 3 (BIN3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call